| Intrinsic Valuation of: EXIDEIND | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 10 | Market Cap | ₹337B | |||||
| 2021 | - | - (-) | P/E Ratio | 40 | Total Asset | ₹214B | |||||
| 2022 | ₹981M | - (-) | Net Income | ₹8B | Total Debt | ₹9B | |||||
| 2023 | ₹-2B | -329.4% (-294.7%) | EBITDA | ₹19B | Total Liab | ₹75B | |||||
| 2024 | ₹-3B | -52.4% (-36.9%) | Opr Margin | 0.07 | Debt/Equity | 0.07 | |||||
| 2025 | ₹-7B | -97.1% (-91.7%) | PreTax Margin | 6.40 | BV/Share | 160 | |||||
| 5Y Average FCF | ₹-3B | -159.6% (-141.1%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (4.0%) | ||||||||||
| 2026 | ₹-3B | MBG Intrinsic Value | ₹89 | ||||||||
| 2027 | ₹-3B | ||||||||||
| 2028 | ₹-3B | ||||||||||
| 2029 | ₹-3B | ||||||||||
| 2030 | ₹-3B | ||||||||||
| 2031 | ₹-4B | ||||||||||
| Terminal Value | ₹-75B | Net Worth/Share | ₹164 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹-64B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹2B | ₹-85 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹9B | WACC | 7.3% | -76 | -80 | -86 | -93 | -102 | |||
| Equity Value | ₹-72B | 7.4% | -75 | -80 | -85 | -92 | -101 | ||||
| Shares Outstanding | 850,000,000 | 7.4% | -75 | -79 | -85 | -92 | -100 | ||||
| 7.9% | -69 | -73 | -78 | -83 | -90 | ||||||
| DCF Intrinsic Value | ₹-85 | 8.4% | -65 | -68 | -72 | -76 | -82 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||